Table 5

CD19 lymphocyte ratios in vitreous samples

	n	Mean	SD	Difference in average value	Effect size: d	p Value
D-sarcoidosis	61	0.42	0.82	0.16	0.26	>0.9999
S-sarcoidosis	60	0.27	0.37	0.16	0.26	>0.9999
D-sarcoidosis	61	0.42	0.82	0.28	0.31	>0.9999
Non-sarcoidosis	16	0.70	0.95	0.28	0.31	>0.9999
D-sarcoidosis	61	0.42	0.82	1.42	0.63	0.1123
Viral infection	20	1.84	3.69	1.42	0.63	0.1123
D-sarcoidosis	61	0.42	0.82	29.06	1.89	<0.0001
Tumour	34	29.48	29.92	29.06	1.89	<0.0001
D-sarcoidosis	61	0.42	0.82	0.54	0.46	0.6018
Unknown	43	0.96	1.53	0.54	0.46	0.6018
S-sarcoidosis	60	0.27	0.37	0.43	0.65	>0.9999
Non-sarcoidosis	16	0.70	0.95	0.43	0.65	>0.9999
S-sarcoidosis	60	0.27	0.37	1.57	0.77	0.0717
Viral infection	20	1.84	3.69	1.57	0.77	0.0717
S-sarcoidosis	60	0.27	0.37	29.21	1.93	<0.0001
Tumour	34	29.48	29.92	29.21	1.93	<0.0001
S-sarcoidosis	60	0.27	0.37	0.69	0.73	0.3762
Unknown	43	0.96	1.53	0.69	0.73	0.3762
Non-sarcoidosis	16	0.70	0.95	1.14	0.49	>0.9999
Viral infection	20	1.84	3.69	1.14	0.49	>0.9999
Non-sarcoidosis	16	0.70	0.95	28.78	1.86	0.0017
Tumour	34	29.48	29.92	28.78	1.86	0.0017
Non-sarcoidosis	16	0.70	0.95	0.26	0.21	>0.9999
Unknown	43	0.96	1.53	0.26	0.21	>0.9999
Viral infection	20	1.84	3.69	27.64	1.64	0.0113
Tumour	34	29.48	29.92	27.64	1.64	0.0113
Viral infection	20	1.84	3.69	0.88	0.34	>0.9999
Unknown	43	0.96	1.53	0.88	0.34	>0.9999
Tumour	34	29.48	29.92	28.52	1.81	<0.0001
Unknown	43	0.96	1.53	28.52	1.81	<0.0001